Olympus Co. (OTCMKTS:OLYMY) Sees Significant Decrease in Short Interest

Olympus Co. (OTCMKTS:OLYMY) saw a large decrease in short interest in July. As of July 31st, there was short interest totaling 17,276 shares, a decrease of 60.1% from the July 15th total of 43,336 shares. Based on an average daily trading volume, of 100,297 shares, the short-interest ratio is presently 0.2 days.

Analyst Ratings Changes

Separately, The Goldman Sachs Group downgraded Olympus from a “buy” rating to a “neutral” rating in a report on Monday, June 15th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold”.

Olympus Stock Down 1.1%

OTCMKTS OLYMY opened at $12.94 on Friday. Olympus has a 12-month low of $8.08 and a 12-month high of $13.73. The company has a fifty day simple moving average of $11.02 and a two-hundred day simple moving average of $10.53.

About Olympus

Olympus Corporation is a Tokyo-based manufacturer specializing in precision technology for the medical, scientific and industrial markets. Established in 1919, the company has built an international reputation for optical and digital imaging solutions that encompass endoscopic systems, microscopes, cameras and related accessories. Olympus leverages its expertise in optics, mechanics and electronics to develop instruments designed to advance diagnostics and scientific discovery.

In the healthcare sector, Olympus is best known for its endoscopy products and therapeutic solutions that support minimally invasive procedures in gastroenterology, pulmonology and urology.